ZYNE #VolatilityWatch by follow_the_money on TradingView.com Zynerba Pharmaceuticals (NASDAQ: ZYNE) announced 5/29/2019, initiation of phase 2 INSIPRE trial for its lead product ZYGEL. ZYGEL is a … [Read more...] about ZYNE– Is this Canna-biz a buy now?
You must be logged in to post a comment.